Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-07-045600
Filing Date
2007-08-21
Accepted
2007-08-21 16:31:22
Documents
1
Period of Report
2007-08-21

Document Format Files

Seq Description Document Type Size
1 v085834_ex.html 4  
1 v085834_ex.xml 4 2959
  Complete submission text file 0001144204-07-045600.txt   4597
Mailing Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3 00000
Business Address KIRYAT WEIZMANN BUILDING 3 REHOVOT76100 ISRAEL L3
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE 20TH FL NEW YORK NY 10022
Business Address
BENTSUR RON (Reporting) CIK: 0001251213 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51310 | Film No.: 071071152